The development centers on merck in charts: Keytruda hits $8.60B, Gardasil bounces back to $1.99B; pharma revenue.
POLARIS INSIGHTS
POLARIS INSIGHTS
The development centers on merck in charts: Keytruda hits $8.60B, Gardasil bounces back to $1.99B; pharma revenue.